6880

Micro-Tech (Nanjing)Ltd Stock Price

Symbol: SHSE:688029Market Cap: CN¥15.5bCategory: Healthcare

688029 Share Price Performance

Community Fair Values

    Recent 688029 News & Updates

    No updates

    Micro-Tech (Nanjing) Co.,Ltd Key Details

    CN¥2.8b

    Revenue

    CN¥986.8m

    Cost of Revenue

    CN¥1.8b

    Gross Profit

    CN¥1.3b

    Other Expenses

    CN¥570.7m

    Earnings

    Last Reported Earnings
    Mar 31, 2025
    Next Reporting Earnings
    Aug 12, 2025
    Earnings per share (EPS)
    3.05
    Gross Margin
    65.18%
    Net Profit Margin
    20.13%
    Debt/Equity Ratio
    0.3%

    Micro-Tech (Nanjing) Co.,Ltd Competitors

     
     
     
     
     
     
     
     
     
     
     
     

    About 688029

    Founded
    1999
    Employees
    2464
    CEO
    Derong Leng
    WebsiteView website
    www.micro-tech.com.cn

    Micro-Tech (Nanjing) Co.,Ltd researches, develops, manufactures, and sells minimally invasive medical devices to hospitals and clinics worldwide. It offers micro-tech endoscopy gastroenterology devices, such as biliary (longwire), biliary (shortwire), biopsy, dilation and hemostasis products, EUS, nitinol stents, resection products, retrieval devices, and accessories; and pulmonology products, such as airway stents, biopsy, dilation balloons, retrieval devices, and accessories. The company also offers OEM/ODM services. Micro-Tech (Nanjing) Co.,Ltd was founded in 1999 and is based in Nanjing, China.

    Chinese Market Performance

    • 7 Days: -1.1%
    • 3 Months: 11.1%
    • 1 Year: 28.8%
    • Year to Date: 11.5%
    Over the last 7 days, the market has dropped 1.1%, driven by a decline of 2.4% in the Industrials sector. In the last year, the market is actually up 29%. Earnings are forecast to grow by 24% annually. Market details ›
    This week, we’re diving deeper into the world of agentic AI. We’re zeroing in on the core technologies that make these intelligent agents actually reliably work. We explore what all this could mean for software, start-ups, and most importantly, the opportunities and risks each industry faces by adopting Agentic AI.
    Continue reading